Board Meeting

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1344.1016.85 (+1.27 %)
PREV CLOSE ( ) 1327.25
OPEN PRICE ( ) 1324.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19192
TODAY'S LOW / HIGH ( )1316.80 1360.00
52 WK LOW / HIGH ( )670 1348
NSE1341.5013.85 (+1.04 %)
PREV CLOSE( ) 1327.65
OPEN PRICE ( ) 1326.70
BID PRICE (QTY) 1341.50 (46)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 719341
TODAY'S LOW / HIGH( ) 1316.05 1360.75
52 WK LOW / HIGH ( )669.8 1348.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.